亚洲知识产权资讯网为知识产权业界提供一个一站式网上交易平台,协助业界发掘知识产权贸易商机,并与环球知识产权业界建立联系。无论你是知识产权拥有者正在出售您的知识产权,或是制造商需要购买技术以提高操作效能,又或是知识产权配套服务供应商,你将会从本网站发掘到有用的知识产权贸易资讯。

3D TAM

总结
A 3D-Printed Biomimetic Tumour Angiogenesis Model
技术优势
A novel in-vitro-screening system for
prescreening of diagnostics and pharmaceuticals as well as testing drugs during tumour therapy
or analysis of tumour growth and tumour angiogenesis.
技术应用
The present invention allows for new strategies in the 3D-cell-printing of tumour models and an alternative to animal testing. On behalf of the University of Aachen, PROvendis is offering access for commercial use in terms of a license.
详细技术说明
Despite major progress in finding alternative methods to animal use in drug discovery and development, laboratory animal testing is in many instances still inevitable. The law also requires animal testing to determine the safety and efficacy of new medicines before testing in humans. To reduce the number of experimental animals, several in-vitro-screening systems have been developed using different 3D-in-vitro-tissue-engineering approaches. However, even though significant progresses have been made, there is still no satisfying in-vitro-screening system available, which might represent a suitable alternative to animal studies.
合作类型
Licensing
申请日期
06/07/2015 00:00:00
申请号码
PCx US 15/323,119
PCx EP 15 747 391.9
其他
No CN patents
ID号码
3871
国家/地区
德国

欲了解更多信息,请点击 这里
移动设备